CN102266487A - 治疗高脂血症的含葛根组合物及制备方法和应用 - Google Patents
治疗高脂血症的含葛根组合物及制备方法和应用 Download PDFInfo
- Publication number
- CN102266487A CN102266487A CN 201110212218 CN201110212218A CN102266487A CN 102266487 A CN102266487 A CN 102266487A CN 201110212218 CN201110212218 CN 201110212218 CN 201110212218 A CN201110212218 A CN 201110212218A CN 102266487 A CN102266487 A CN 102266487A
- Authority
- CN
- China
- Prior art keywords
- radix puerariae
- contain
- hyperlipemia
- parts
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 201000005577 familial hyperlipidemia Diseases 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 title abstract 4
- 241000219781 Pueraria montana var. lobata Species 0.000 title 1
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 53
- 239000003814 drug Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000012567 medical material Substances 0.000 claims description 19
- 235000008597 Diospyros kaki Nutrition 0.000 claims description 13
- 235000013361 beverage Nutrition 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims description 4
- 235000019260 propionic acid Nutrition 0.000 claims description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 4
- 235000010234 sodium benzoate Nutrition 0.000 claims description 4
- 239000004299 sodium benzoate Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 235000021374 legumes Nutrition 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 13
- 210000004185 liver Anatomy 0.000 abstract description 7
- 235000011511 Diospyros Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 abstract 1
- 229960004245 silymarin Drugs 0.000 abstract 1
- 235000017700 silymarin Nutrition 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000004064 recycling Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010039020 Rhabdomyolysis Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 244000152526 Agathosma crenulata Species 0.000 description 1
- 235000013388 Agathosma crenulata Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000009269 Barosma crenulata Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 244000113306 Monascus purpureus Species 0.000 description 1
- 235000002322 Monascus purpureus Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003616 anti-epidemic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940062650 buchu Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 210000003459 common hepatic duct Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
葛根 | 水飞蓟 | 玉竹 | 桑叶 | 柿叶 | 甘草 | |
实施例1 | 10 | 15 | 5 | 20 | 10 | 30 |
实施例2 | 20 | 10 | 10 | 18 | 20 | 20 |
实施例3 | 30 | 5 | 15 | 15 | 30 | 10 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110212218XA CN102266487B (zh) | 2011-07-28 | 2011-07-28 | 治疗高脂血症的含葛根组合物及制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110212218XA CN102266487B (zh) | 2011-07-28 | 2011-07-28 | 治疗高脂血症的含葛根组合物及制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102266487A true CN102266487A (zh) | 2011-12-07 |
CN102266487B CN102266487B (zh) | 2012-07-25 |
Family
ID=45049067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110212218XA Expired - Fee Related CN102266487B (zh) | 2011-07-28 | 2011-07-28 | 治疗高脂血症的含葛根组合物及制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102266487B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102630976A (zh) * | 2012-03-30 | 2012-08-15 | 池州市昭明渔港酒店 | 一种解酒鱼肉包子及其制作方法 |
CN102630975A (zh) * | 2012-03-30 | 2012-08-15 | 池州市昭明渔港酒店 | 一种解酒护肝鱼肉包子及其制作方法 |
CN102630977A (zh) * | 2012-03-30 | 2012-08-15 | 池州市昭明渔港酒店 | 一种鱼肉包子及其制作方法 |
CN102640943A (zh) * | 2012-03-30 | 2012-08-22 | 池州市昭明渔港酒店 | 一种护肝鱼肉包子及其制作方法 |
CN103751547A (zh) * | 2014-01-21 | 2014-04-30 | 四川绿禾药业有限公司 | 一种降血脂的中药组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101731407A (zh) * | 2010-02-11 | 2010-06-16 | 李寿山 | 具有三降作用的苦丁茶饮料及其制作方法 |
-
2011
- 2011-07-28 CN CN201110212218XA patent/CN102266487B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101731407A (zh) * | 2010-02-11 | 2010-06-16 | 李寿山 | 具有三降作用的苦丁茶饮料及其制作方法 |
Non-Patent Citations (3)
Title |
---|
《中医药学刊》 20060828 苏孝共等 降脂中药的性效辨析及机理探讨 1564-1565 1-9 , 第08期 * |
《吉林中医药》 20040820 刘红跃 高脂血症的中医药治疗研究进展 56-57 1-9 , 第08期 * |
《陕西中医》 19870105 吕兰薰 降血脂中药的研究动态 28 1-9 , 第01期 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102630976A (zh) * | 2012-03-30 | 2012-08-15 | 池州市昭明渔港酒店 | 一种解酒鱼肉包子及其制作方法 |
CN102630975A (zh) * | 2012-03-30 | 2012-08-15 | 池州市昭明渔港酒店 | 一种解酒护肝鱼肉包子及其制作方法 |
CN102630977A (zh) * | 2012-03-30 | 2012-08-15 | 池州市昭明渔港酒店 | 一种鱼肉包子及其制作方法 |
CN102640943A (zh) * | 2012-03-30 | 2012-08-22 | 池州市昭明渔港酒店 | 一种护肝鱼肉包子及其制作方法 |
CN102630975B (zh) * | 2012-03-30 | 2013-11-20 | 池州市昭明渔港酒店 | 一种解酒护肝鱼肉包子及其制作方法 |
CN102640943B (zh) * | 2012-03-30 | 2013-11-20 | 池州市昭明渔港酒店 | 一种护肝鱼肉包子及其制作方法 |
CN102630977B (zh) * | 2012-03-30 | 2013-11-20 | 池州市昭明渔港酒店 | 一种鱼肉包子及其制作方法 |
CN102630976B (zh) * | 2012-03-30 | 2013-11-20 | 池州市昭明渔港酒店 | 一种解酒鱼肉包子及其制作方法 |
CN103751547A (zh) * | 2014-01-21 | 2014-04-30 | 四川绿禾药业有限公司 | 一种降血脂的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102266487B (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101518580B (zh) | 清热解毒的药物组合物及其制备方法和用途 | |
CN102266487B (zh) | 治疗高脂血症的含葛根组合物及制备方法和应用 | |
CN111012876A (zh) | 一种改善睡眠的产品及其制备方法和用途 | |
CN104383259A (zh) | 一种苦瓜桑叶富铬胶囊及其制备方法 | |
CN103479691B (zh) | 降脂保肝中药组合物 | |
CN102068521B (zh) | 一种用于治疗高脂血症的中药组合物及其制备方法和应用 | |
CN102935152B (zh) | 一种用于治疗高脂血症的中药组合物及其制备方法和应用 | |
CN102961584B (zh) | 一种抗疲劳的中药组合物及其制备方法和应用 | |
CN102614280B (zh) | 一种具有降低血脂功效的中药组合物及其制备方法和应用 | |
CN102697843B (zh) | 一种清肠通便排毒养颜保健品及其制备方法 | |
CN101884671B (zh) | 基于治未病和药食同源理论的防治哮喘的食疗制剂 | |
CN102846879A (zh) | 一种降血脂的组合物 | |
CN106072132A (zh) | 一种大枣食品 | |
CN103520302A (zh) | 一种沙棘叶抗疲劳胶囊及其制备方法 | |
CN103566349B (zh) | 一种治疗高血糖高血脂的药物组合物 | |
CN102698202B (zh) | 一种用于治疗胆结石的中药组合物及其制备方法和应用 | |
CN101612254A (zh) | 一种具有抗疲劳、免疫调节作用的药物组合物及其制备方法 | |
CN106266573A (zh) | 一种抗疲劳、抗衰老的复方制剂及其制备方法 | |
CN102178873B (zh) | 一种包括外用剂和内服剂相组合的中药减肥制剂及其制备方法 | |
CN103919972B (zh) | 一种抗疲劳的药物组合物及其制备方法和应用 | |
CN102462787A (zh) | 治疗高血压、改善高血脂的中药组合物及其制剂方法 | |
CN114712466B (zh) | 一种具有减肥养颜功效的药物及其制备方法 | |
CN107412369A (zh) | 一种三七花助眠药用组合物 | |
CN104906429A (zh) | 一种谷物膳食纤维组合物 | |
CN105560551A (zh) | 用于治疗高血脂疾病的中药组合物及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HUANG QINGXI Free format text: FORMER OWNER: NANJING ZHENGKUAN PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. Effective date: 20130115 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 211200 NANJING, JIANGSU PROVINCE TO: 410011 CHANGSHA, HUNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130115 Address after: 410011 Hunan province Changsha Furong Road two No. 111 Hualing building 21 floor Patentee after: Huang Qingxi Address before: Qingfeng Village Yong Yang town of Lishui County of Nanjing City, Jiangsu province 211200 Green Village building 301 room 22 Patentee before: NANJING ZHENGKUAN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: CENTRAL BIOVALLEY TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HUANG QINGXI Effective date: 20130208 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130208 Address after: 410011, room 21, building 259, Hualian building, 21 Furong Road, Furong district, Hunan, Changsha Patentee after: Central biological Valley Technology Co.,Ltd. Address before: 410011 Hunan province Changsha Furong Road two No. 111 Hualing building 21 floor Patentee before: Huang Qingxi |
|
ASS | Succession or assignment of patent right |
Owner name: HUNAN MIDDLE BIOON GROUP TECHNOLOGY INCUBATOR CO., Free format text: FORMER OWNER: CENTRAL BIOVALLEY TECHNOLOGY CO., LTD. Effective date: 20130322 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 410011 CHANGSHA, HUNAN PROVINCE TO: 410116 CHANGSHA, HUNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130322 Address after: Office building of Wanjiali road 410116 in Hunan province Changsha Yuhua District, two No. 18 Hunan environmental science and Technology Industrial Park Management Committee building 459 room four Patentee after: Hunan central Bio Valley Technology Incubator Co.,Ltd. Address before: 410011, room 21, building 259, Hualian building, 21 Furong Road, Furong district, Hunan, Changsha Patentee before: Central biological Valley Technology Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Office building of Wanjiali road 410116 in Hunan province Changsha Yuhua District, two No. 18 Hunan environmental science and Technology Industrial Park Management Committee building 459 room four Patentee after: Health Science and Technology Co.,Ltd. Address before: Office building of Wanjiali road 410116 in Hunan province Changsha Yuhua District, two No. 18 Hunan environmental science and Technology Industrial Park Management Committee building 459 room four Patentee before: Hunan central Bio Valley Technology Incubator Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 |